Hepatitis B Virus
NASH ‘fastest growing cause’ of liver cancer death worldwide
Despite global declines in liver cancer mortality attributed to hepatitis B and C, liver cancer mortality rose sharply in the Americas, driven by an increase in nonalcoholic steatohepatitis, according to data published in Cell Metabolism.
Heavy alcohol use, gene variant heighten risk for HCC, mortality in HBV-related cirrhosis
Patients with cirrhosis who have hepatitis B virus infection and a history of heavy alcohol use are at higher risk for hepatocellular carcinoma and mortality, according to a study published in JAMA Network Open.
VIDEO: ‘We need to do more’ to attain HBV elimination
In a Healio video exclusive, Chari Cohen, DrPH, MPH, president of the Hepatitis B Foundation, and Jeff Baxter, president and CEO of VBI Vaccines, shared insights on the latest efforts in HBV treatment and prevention.
Children younger than 12 years now exempt from pretransplant HIV, HBV, HCV testing
The U.S. Public Health Service has published an updated recommendation for solid organ transplant candidates aged younger than 12 years, which now exempts them from testing for HIV and hepatitis B and C viruses during surgical admission.
VIDEO: ‘Critical to test’ for HBV, latent TB coinfection to reduce liver injury
In a Healio video exclusive, Harvey Kaufman, MD, senior medical director at Quest Diagnostics, highlighted the need for concurrent hepatitis B and latent tuberculosis testing to mitigate the risk for drug-induced liver injury.
HBV-listed death rates surpass national average in coastal, Appalachian states
Individuals born in the United States made up nearly two-thirds of all hepatitis B-listed deaths, with death rates exceeding the national average in 13 states, according to research published in JAMA Network Open.
Few PCPs implementing universal HBV vaccination guidance
It is finally possible to eliminate hepatitis B virus in the United States, as long as a multipronged strategy is used to fully implement new guidance that recommends universal vaccination for adults aged 19 to 59 years, experts said.
‘Strong support, political will’ needed to achieve global HBV, HCV elimination goals
LONDON —Although progress has been made, nearly 12 million individuals will die early from preventable hepatitis B and hepatitis C deaths without additional interventions, according to research presented at the International Liver Congress.
Low-cost scoring system informs HBV treatment eligibility in resource-limited countries
SAN DIEGO — A new, low-cost scoring system called TREAT-B accurately determined treatment eligibility for patients with hepatitis B virus, particularly where DNA assays are unavailable, according to research.
Hepatitis Awareness Month: acute hepatitis in children, WHO guidance and more
May is Hepatitis Awareness Month, and the CDC and its public health partners are raising awareness and encouraging increased screening and vaccination.